Clinical trial
Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia
NCT03999190 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia
- Lead sponsor
- NYU Langone Health
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- July 31, 2019
- Completion date
- July 31, 2025
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.